chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in arm; fatigue; severe headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), HEADACHE (severe headache) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm), HEADACHE (severe headache) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (pain in arm), HEADACHE (severe headache) and FATIGUE (fatigue) had resolved.
30 minutes after given vaccine lost vision on right eye with blotches of black imagines obscuring vision on right eye.  Symptoms went away in 5 seconds.  Was not feeling any discomfort at all as it happened. Today 9/14/21, nearly 6 months after being given original shot, had identical symptoms, in the same right eye, the symptoms went away within 5 seconds like before.  Was not feeling any discomfort or otherwise anything out of the ordinary.
On September 30,2023, the donor reported feeling dizzy and nauseous while waiting in the donor recovery area approximately 10 minutes after receiving the rabies booster immunization.  Donor stated nausea subsided after consuming one 16-ounce Gatorade and all symptoms resolved after rest, elevating his legs and consuming a 2nd 16-ounce Gatorade. Donor left the center in good condition.
retinal bleed/hemorrhage. Patient reports she had it 2 weeks after her first pfizer vaccine. She had an eye exam 3 weeks prior without any signs of macular, and then suddenly a pop in her eye, a central black spot and dx of wet macular and retinal hemorrhage.
the patient received improperly stored dose of PROQUAD; NO ADVERSE EFFECT; This spontaneous report as received from a Nurse regarding to a patient of unknown age and gender. The patients' pertinent medical history,and drug reactions/allergies were not reported. The concomitant medication included sterile diluent which was reported to be stored properly.  On 25-APR-2019, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # R015741, expiry date: 02-DEC-2019) for prophylaxis.  It was reported that the vaccine was exposed to temperature of 6 degree Fahrenheit to 14 degree Fahrenheit (-14 degree Celsius to -10 degree celsius) (7.9 Fahrenheit) for a time frame 1 hour 55 minutes and temperature 6 degree Fahrenheit to 14 degree Fahrenheit (-14 degree celsius to -10 degree celsius) (10.4 Fahrenheit) for a time frame 3 hour 15 minutes. There was previous temperature excursion was reported. Data logger was involved. No adverse effects were reported. No additional information was provided.   Albumin status for lot number R015741 was rHA.
Temperature to 104.9 despite tylenol and ibuprophen normal 98.9 post injection right anterior thigh swollen erythematus fever continued for second day cellulitis treated with Amoxicilin 250 TID 5 days
pt recv vax 12MAY97 & 20JUN97 lab eval revealed a varicella titer of 0.23;
pt had generalized malaise & low grade fever which was treated w/amoxicillin on 11JUL92; pt vaxed w/measles on 22JUL92 & 23JUL92 stated did not feel well & had fever; c/o sore throat, coughing, loose stools, t102, blotching, mild abdo pain;
Bump under skin (flat but wide- around 4 inches), itchiness, sore, red
Body aches, Headache, Fatigue, Nausea, Abdominal cramping.
Patient experienced pain at site of injection ~4-6 times per day whereby she must massage area with force to alleviate pain.  She has had a few times where she has lost strength in her left arm and dropped a laundry basket at home.
Prolonged, heavier periods. Abnormal cramps, spotting between periods, abnormal discharge. Every month since first vaccination shot.
Fever; Chills; I lost consciousness; Arrhythmia; Booster; Tiredness; Arm was sore; Little bit of headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non healthcare professional). The reporter is the patient.  A 35 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Dec2021 (Lot number: FE3594) at the age of 35 years as DOSE NUMBER UNKNOWN (BOOSTER), SINGLE for covid-19 immunization. The patient had no relevant medical history. The patient had no any other vaccinations within 4 weeks. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE NUMBER UNKNOWN, Manufacturer Unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (medically significant) with onset 21Dec2021, outcome "unknown", described as "Booster"; LOSS OF CONSCIOUSNESS (medically significant) with onset 22Dec2021, outcome "unknown", described as "I lost consciousness"; ARRHYTHMIA (medically significant) with onset 22Dec2021, outcome "unknown", described as "Arrhythmia"; FATIGUE (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "Tiredness"; PYREXIA (non-serious) with onset 22Dec2021, outcome "unknown", described as "Fever"; CHILLS (non-serious) with onset 22Dec2021, outcome "unknown", described as "Chills"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "Arm was sore"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Little bit of headache". Therapeutic measure ibuprofen was taken as a result of pyrexia, pain in extremity, headache.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age (gender not reported). The patient was vaccinated with the first, second and third dose of GARDASIL (lot #, route, dose not reported) on 12-JUN-2007, 13-AUG-2007 and 17-OCT-2007 respectively. No adverse effects reported. It was unspecified if the patient seek medical attention or not. Additional information has been requested.
Patient received monovalent pfizer vaccine instead of bivalent pfizer for booster dose. No adverse events.
Severe shaking chills for 4-5 hrs the evening after the High dose flu injection.
Generalized papulovesicular rash face, neck, torso, arms 1 day after vaccine administered.
sore arm; throbbing; this weekend he can barely move it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 (Lot number: ER8733) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose no.: 1, Lot no.: EN6205, left arm), administration date: 09Mar2021, when the patient was 35 years old, for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "sore arm"; PAIN (non-serious), outcome "not recovered", described as "throbbing"; Vaccination site movement impairment (non-serious), outcome "not recovered", described as "this weekend he can barely move it". Additional Information: Patient informed that he got the second dose at the end of March, and his arm has been sore but this weekend he could barely move it. It is throbbing right now. Sore arm, throbbing: caller states it was sore from the injection but it never went away.  It is sore really bad, he can barely move it.  On a scale of 1 to 10, it is a 6.5 or 7.  It is only at the injection site and nowhere else in the arm.  It is his left arm.  Caller adds he was about to go to the doctor today which is why he is calling.  No follow-up attempts are possible. No further information is expected.
Sore arm for a day and half; Headache the entire day after the shot; Shortness of breath on and off for 2 weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 14Aug2021 16:45 (Lot number: Fl3180) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBUPROFEN. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 16Aug2021, outcome "recovered" (Aug2021), described as "Sore arm for a day and half"; HEADACHE (non-serious) with onset 16Aug2021, outcome "recovered" (Aug2021), described as "Headache the entire day after the shot"; DYSPNOEA (non-serious) with onset 16Aug2021, outcome "recovering", described as "Shortness of breath on and off for 2 weeks". Therapeutic measures were not taken as a result of pain in extremity, headache, dyspnoea.  Additional information: Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19 and since the vaccination, has the patient not tested for COVID-19. The patient did not received any treatment for the adverse events.  Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
pt recv vax 2DEC96 & 11DEC96 pt devel a fever & a rubella-like rash, which started @ the area of inj;11DEC96 mean platelet volume was 7.3fl (low) & the rubella IgM titer was 0.2 (negative);16DEC96 lab eval revealed IgG less than 5 & IgM 0.7
Open angle borderline glaucoma/glaucoma suspect.  Copied from doctor's note: "Open angle borderline glaucoma in both eyes - Based on C/D. Pachy (-1), OCT RNFL 85/86"
This spontaneous report was received from a registered nurse and refers to a 26 year old female patient. The patient had no pertinent medical history and no drug reactions or allergies. On 24-MAR-2016 (also reported as recently), the patient was vaccinated "in ob office" with the first dose of GARDASIL series, injection (route and site of administration, dose, lot number and expiration date were not reported). Concomitant therapies included ORTHO-CYCLEN and topical tretinoin. On approximately 14-APR-2016 (reported as "on or around 14-APR-2016") a "raised circular area" appeared "near or at" the GARDASIL injection site. On 18-APR-2016, the patient came back to the registered nurse office to report this event. The nurse reported that raised area felt "like a sterile abscess", it was about 2 centimeters wide, "felt like it was filled with water" and was tender. The patient stated that she could "move it", but there was no redness or fever present. The reporting nurse stated that the patient did not recall experiencing any trauma to the site and it did not appear to be an insect bite. Apart from physical examination, no lab diagnostic studies were performed. The patient was advised to administer TYLENOL or ALEVE for treatment of the events and was informed to monitor the site and then call the office back in 2 days. On 21-APR-2016, the patient called back and stated that it was "actually a little bit bigger". On an unknown date in approximately April 2016 (reported as "one month later" in regards to the vaccination), the patient presented to the office complaining of swelling, tenderness at the injection site and reported increased pain (onset date on an unknown date in 2016), no fever and no erythema. The reporter stated that the patient had "palpable mass, tender, mobile, circular in shape that was 1-2 centimeters in diameter" (onset date on an unknown date in 2016). The nurse practitioner, who ordered the vaccination series was questioning if this could be a delayed reaction, asking for advice. The patient sought medical attention as she called and visited the nurse practitioner office. The outcome of raised area, which felt "like a sterile abscess" and was tender was reported as not recovered/not resolved. The outcome of palpable mass, swelling at the injection site and increased pain was not reported. The relatedness between all the events and the vaccination with GARDASIL was not reported. Additional information has been requested.
Itching, redness, warmth by report of pt seen by Dr placed on Benadryl OTC.
Client reports that she started feeling a dry spot in the back of her throat that made it slightly difficult to breath around 1/2 hour following vaccine.  She consulted with the nurse administering the vaccine and decided it would be okay to leave the vaccination site.  She reported that the dry spot on the back of her throat became more prominent and it was more difficult to swallow around an hour after receiving the vaccine.   She decided to go to the ER as a precaution because she lives far from the hospital.  At the ER they gave her 75 mg of Benadryl and 15 mg of prednisone.  Her symptoms resolved following the medications.
Left arm cellulitic reaction to DTaP and IPV vaccination. Placed on Zithromax as allergy to Cephalexin.
Patient was given expired vaccination. He was advised to have repeat injection with non-expired vaccine while in office. He was agreeable with this. Patient did not have any adverse reactions to either injections.
Pt developed dizziness shortly after vaccination. She denied prior history of similar reactions. HR 54, BP 80/50, SP02 99%. HR improved to 60 and BP improved to 100/70. Symptoms improved after 15-20 minutes of observation.
pt visiting parent & became ill w/severe retching & vomiting, but no nausea; also had weakness & dizziness so severe that could not open eyes; had broken blood vessels in sclera & around eyes; devel blood in emesis; seen @ ER;
Caller wants to know if she can get the dose tomorrow when she still have colds.; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch Number/Lot Number were not reported) via unspecified route of administration on 07Jul2021 at DOSE 1, SINGLE for COVID-19 Immunization. The patient's medical history and concomitant medications were not reported. The patient experienced on 21Jul2021 and it was reported, recently this Friday, she caught a cold and the symptoms started on Wednesday and Thursday. The patient wants to know if she can get the dose tomorrow when she still have colds. Consumer who received the first dose of the Pfizer Biontech COVID19 vaccine on 07Jul2021 and is scheduled to receive the second dose on 27Jul2021 (tomorrow). The clinical outcome of the event was unknown.  Information on the lot/batch number has been requested.
runny nose; fever; could not find a place to receive the second vaccine; could not find a place to receive the second vaccine; This spontaneous case was reported by a physician and describes the occurrence of RHINORRHOEA (runny nose), PYREXIA (fever), PRODUCT ADMINISTRATION INTERRUPTED (could not find a place to receive the second vaccine) and PRODUCT AVAILABILITY ISSUE (could not find a place to receive the second vaccine) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (could not find a place to receive the second vaccine) and PRODUCT AVAILABILITY ISSUE (could not find a place to receive the second vaccine). On 21-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RHINORRHOEA (runny nose) and PYREXIA (fever). On 26-Jul-2021, RHINORRHOEA (runny nose) and PYREXIA (fever) had resolved. At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (could not find a place to receive the second vaccine) and PRODUCT AVAILABILITY ISSUE (could not find a place to receive the second vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.  Patient got the second dose after the recommended window.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received Added second dose details, events of second dose, outcome of the event.updated reporter details.
Patient started to cry about 4 hours after shot.  About 6 hours after shot, she spiked a fever of 101.5, turned red, started vomiting and had bouts of diarrhea.  She stopped crying and became listless bordering unresponsive.  When I tried to rouse her, she made weird moaning sounds and her eyes would open and roll back in her head.  I called the 24 hour nurse who said if her fever didn't go above 102, to keep her home and hydrated.  I stayed up all night to make sure she kept breathing because her body was so limp and lifeless.  She didn't turn or do anything throughout the night.  She moved a little when she vomited.  She didn't nurse for 14 hours after symptoms first appeared.  I reported all these symptoms to Dr her next appt and she said they were all normal reactions and she should have two more booster vaccines.  I asked if she could have them individually to see what she reacted to so severely, and she said that wasn't cost effective.  I declined the boosters out of concern that future reactions could have more severe outcomes.   After the vaccine, patient developed numerous food sensitivities.  She gained weight more slowly and was diagnosed failure to thrive at 2 yo by gastroenterologist.  She had an endoscopy and colonoscopy a year later, and they found chronic inflammation from her esophagus to her colon.  They rules out chrohn's, celiac, and every other inflammatory bowel disease.  Her immunologist said her immune system was malfunctioning and "always" on.  She had chronic stomach bloat and diarrhea.  She was sick about 7 months a year.  Her sensitivity to some foods resulted her pink eye which she got about twice a month, every month. This was her new life post her one and only pentacel vaccine.
Pfizer booster:Patient is reporting a rash all over body, looks like hives. Rash is red, hot and swollen and when rash goes away, it appears like a bruise.
Stabbing pain in arm during 1st dose; 1st dose more painful than other shots; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Stabbing pain in arm during 1st dose) and VACCINATION SITE PAIN (1st dose more painful than other shots) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Stabbing pain in arm during 1st dose) and VACCINATION SITE PAIN (1st dose more painful than other shots). At the time of the report, PAIN IN EXTREMITY (Stabbing pain in arm during 1st dose) and VACCINATION SITE PAIN (1st dose more painful than other shots) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports not having excessive bleeding after the 1st dose.   Concomitant product use was not provided by the reporter.    Treatment ice pack for pain.   This case was linked to MOD-2021-148615 (Patient Link).
pt recv vax 10FEB99 & w/in 1 1/2 to 2wk began noticing inc hair loss;hair loss worse p/washing & blow drying;hair noticeably thinner;
I started having chest pain some time this morning and it made it somewhat difficult to continue sleeping. It hurts when I breathe but it also hurts while I'm just sitting here. I've taken a hot shower and right now I'm breathing in steam. I've been hacking up phlegm. It's a very sharp stabbing pain.
Patient developed severe diarrhea after 1st ROTATEQ >10 stools per day x2 weeks. Resolved - needed Pregestemol.
Tested positive for Covid-19 after experiencing mild symptoms; Tested positive for Covid-19 after experiencing mild symptoms; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in the left arm on 01Mar2021 (at the age of 46 years old) (Batch/Lot Number: EN6203) as a single dose and dose 2 via an unspecified route of administration, administered in the left arm on 24Mar2021 (at the age of 46 years old) (Batch/Lot Number: EN6203) as a single dose, for covid-19 immunisation at workplace clinic. The patient had no medical history and no known allergies. There were no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient tested for COVID-19. On 01Oct2021, the patient tested positive for Covid-19 after experiencing mild symptoms. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 01Oct2021 (Nasal Swab). The patient received no treatment for the event. The outcome of Covid-19 was recovering.  No follow-up attempts possible. No further information expected.
About an hour after vaccine she began feeling light headed and nauseous - strong for about an hour, then eased up for about 2 hours, then hit hard- - complains of nausea, severe aches and pains throughout body, inability to lift left arm (site of shot), and occasional numbness in legs - has been unable to keep food down since vaccine
WITHIN 24 HRS OF 1ST ENGERIX-B INJECTION, PT EXP LOOSE STOOLS(4 THAT EVENING, ONE THE NEXT MORN, AND NO MORE SINCE). PT TOOK LOMOTIL. PT ALSO REPORTED NAUSEA.
Narrative:  When patient was asked about side effects after first dose she described an episode of rash on her chest and face following the administration
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date an unspecified number of patients were vaccinated with VARIVAX (Merck) injection (lot number and expiry date unknown) (dose 0.5 ml, frequency unknown) subcutaneously which on an unknown date had undergone a temperature excursion (details unspecified). No adverse events were reported. No product quality issue was reported. The action taken with the VARIVAX (Merck) therapy and the outcome of the events was unknown. The relatedness of the events to the therapy with VARIVAX (Merck) was unknown. Follow up information has been received on 09-DEC-2014. The reporter provided the lot numbers. This case includes lot number # K006138, expiration: 29-APR-2016 and doses to be returned 10. This case is linked to the case 1412USA008276 and 1411USA011908 (same reporter link). Additional information has been requested.